480418 Sigma-AldrichNF279 - CAS 202983-32-2 - Calbiochem
A suramin analog that acts as a highly selective, competitive, and reversible ATP-antagonist of P2X receptor (IC₅₀/KB ~ 1 µM in smooth muscle).
More>> A suramin analog that acts as a highly selective, competitive, and reversible ATP-antagonist of P2X receptor (IC₅₀/KB ~ 1 µM in smooth muscle). Less<<Synonyms: 8,8ʹ-(Carbonylbis(imino-4,1-phenylenecarbonylimino-4,1-phenylenecarbonylimino))bis-1,3,5-naphthalenetrisulfonic Acid, Na
Recommended Products
Overview
| Replacement Information |
|---|
Key Spec Table
| CAS # | Empirical Formula |
|---|---|
| 202983-32-2 | C₄₉H₃₀N₆O₂₃S₆ · 6Na |
Pricing & Availability
| Catalogue Number | Availability | Packaging | Qty/Pack | Price | Quantity | |
|---|---|---|---|---|---|---|
| 480418-5MGCN |
|
Plastic ampoule | 5 mg |
|
— |
| Product Information | |
|---|---|
| CAS number | 202983-32-2 |
| ATP Competitive | Y |
| Form | White solid |
| Hill Formula | C₄₉H₃₀N₆O₂₃S₆ · 6Na |
| Chemical formula | C₄₉H₃₀N₆O₂₃S₆ · 6Na |
| Reversible | Y |
| Structure formula Image | |
| Quality Level | MQ100 |
| Applications |
|---|
| Physicochemical Information | |
|---|---|
| Cell permeable | Y |
| Dimensions |
|---|
| Materials Information |
|---|
| Toxicological Information |
|---|
| Safety Information according to GHS |
|---|
| Safety Information |
|---|
| Product Usage Statements |
|---|
| Packaging Information | |
|---|---|
| Packaged under inert gas | Packaged under inert gas |
| Transport Information |
|---|
| Supplemental Information |
|---|
| Specifications |
|---|
| Global Trade Item Number | |
|---|---|
| Catalogue Number | GTIN |
| 480418-5MGCN | 04055977201352 |
Documentation
NF279 - CAS 202983-32-2 - Calbiochem SDS
| Title |
|---|
NF279 - CAS 202983-32-2 - Calbiochem Certificates of Analysis
| Title | Lot Number |
|---|---|
| 480418 |
References
| Reference overview |
|---|
| Klapperstück, M., et al. 2000. Eur. J. Pharmacol. 387, 245. Rettinger, J., et al. 2000. Neuropharmacol. 39, 2044. Lambrecht, G., et al. 1999. Prog. Brain Res. 120,107. Damer, S., et al. 1998. Eur. J. Pharmacol. 350, R5. |



